Inventor

KONRADI ANDREI W

US77 patents

⚠️ This page may combine multiple inventors who share the name “KONRADI ANDREI W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KONRADI ANDREI W

ELAN PHARM INC

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

α-aminoacetic acid derivatives-α4β7 receptor antagonists

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4

αaminocetic acid derivatives- α4β7 receptor antagonists

Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Bridged N-cyclic sulfonamido inhibitors of gamma secretase

5-(arylsulfonyl)-pyrazolopiperidines

Bridged N-cyclic sulfonamido inhibitors of gamma secretase

WYETH CORP

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

(unassigned)

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4

CORTEXYME INC

Aminopyridine compounds and methods for the preparation and use thereof

Inhibitors of lysine gingipain

Ketone inhibitors of lysine gingipain

Inhibitors of lysine gingipain

ATHENA NEUROSCIENCES INC

Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4

VIVACE THERAPEUTICS INC

Bicyclic compounds

ALGEN BIOTECHNOLOGIES INC

Certain chemical compositions and methods of use thereof

KONRADI ANDREI W

Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds